Adaptimmune Therapeutics PLC (NASDAQ:ADAP)

1.07
BATS BZX Real-Time Price
As of 10:43am ET
 +0.01 / +0.94%
Today’s Change
1.01
Today|||52-Week Range
2.65
-26.71%
Year-to-Date
No recent news for Adaptimmune Therapeutics PLC.

Today’s Trading

Previous close1.06
Today’s open1.09
Day’s range1.07 - 1.09
Volume2,610
Average volume (3 months)501,180
Market cap$180.2M
Data as of 10:43am ET, 03/30/2023

Growth & Valuation

Earnings growth (last year)-1.10%
Earnings growth (this year)-289.41%
Earnings growth (next 5 years)+5.60%
Revenue growth (last year)+341.28%
P/E ratioNM
Price/Sales8.67
Price/Book2.19

Competitors

 Today’s
change
Today’s
% change
XXII22nd Century Group I...+0.03+3.58%
LRMRLarimar Therapeutics...-0.05-1.15%
SELBSelecta Biosciences ...+0.05+3.89%
TCRTAlaunos Therapeutics...+0.01+2.28%
Data as of 11:01am ET, 03/30/2023

Financials

Next reporting dateMay 8, 2023
EPS forecast (this quarter)-$0.19
Annual revenue (last year)$27.1M
Annual profit (last year)-$165.4M
Net profit margin-609.46%

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
Abingdon, Oxfordshire

Forecasts